171
Participants
Start Date
March 29, 2012
Primary Completion Date
November 11, 2013
Study Completion Date
November 21, 2013
Gefapixant
BID
Sugar Pill
Placebo
Afferent Investigative Site, Duncansville
Afferent Investigative Site, Roanoke
Afferent Investigative Site, Winston-Salem
Afferent Investigative Site, Greensboro
Afferent Investigative Site, Asheville
Afferent Investigative Site, Mt. Pleasant
Afferent Investigative Site, Greer
Afferent Investigative Site, Atlanta
Afferent Investigative Site, Orlando
Afferent Investigative Site, Clearwater
Afferent Investigative Site, Pinellas Park
Afferent Investigative Site, Olive Branch
Afferent Investigative Site, Toledo
Afferent Investigative Site, Cincinnati
Afferent Investigative Site, Troy
Afferent Investigative Site, Kenosha
Afferent Investigative Site, Hazelwood
Afferent Investigative Site, St Louis
Afferent Investigative Site, Wichita
Afferent Investigative Site, Dallas
Afferent Investigative Site, Houston
Afferent Investigative Site, San Antonio
Afferent Investigative Site, San Antonio
Afferent Investigative Site, Austin
Afferent Investigative Site, Clinton
Afferent Investigative Site, Phoenix
Afferent Investigative Site, Phoenix
Afferent Investigative Site, Albuquerque
Afferent Investigative Site, San Diego
Afferent Investigative Site, Medford
Afferent Investigative Site, Renton
Afferent Investigative Site, New Bedford
Afferent Investigative Site, Watertown
Afferent Investigative Site, Warwick
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
INDUSTRY